Early Phase 1 Amyotrophic Lateral Sclerosis Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Johns Hopkins University24 enrolled1 locationNCT06656702

Recruiting

Early Phase 1

[18F]ACI-19626 PET in TDP-43 Proteinopathies

Amyotrophic Lateral Sclerosis(ALS)Alzheimer's Disease(AD)Frontotemporal Dementia (FTD)+2 more

AC Immune SA45 enrolled1 locationNCT06891716

Recruiting

Early Phase 1

A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

Amyotrophic Lateral Sclerosis(ALS)

Hong Chen6 enrolled1 locationNCT06849609